REQUEST A DEMO
Total
USD $0.00
Search more companies

Poli Pharm Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Poli Pharm Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Poli Pharm Company Limited is based in Thailand. The head office is in Samut Prakan. The company operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 15, 1978. It currently has a total number of 255 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 7.15% in 2024. A growth of 12.85% was recorded in its total assets. The net profit margin of Poli Pharm Company Limited decreased by 0.43% in 2024.

Headquarters
109 Moo 12 Bang Na-Trad Road
Samut Prakan; Central Thailand; Postal Code: 10540

Contact Details: Purchase the Poli Pharm Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Poli Pharm Company Limited report to view the information.
Financial Auditors:
Purchase the Poli Pharm Company Limited report to view the information.
Incorporation Date:
May 15, 1978
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Poli Pharm Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
7.15%
Total Operating Revenue
7.55%
Operating Profit
22.63%
EBITDA
22.63%
Net Profit/Loss for the Period
4.76%
Total Assets
12.85%
Total Equity
8.72%
Operating Profit Margin
2.76%
Net Profit Margin
-0.43%
Return on Equity (ROE)
-0.77%
Quick Ratio
-2.13%
Cash Ratio
-0.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?